Department of Radiation Biology
Department head: Professor Kristian Berg.
Department secretary: Siri Mette Jebsen
Department of Radiation Biology is organized in five different groups and four project groups.
| PCI | Biophysics & PDT group | Radiation biology & tumor physiology | Molecular Radiation Biology |
|
|
|
|
|
| Kristian Berg | Johan Moan | Einar Rofstad | Trond Stokke |
Project groups:
Radioimmunotherapy
Clinical Radiation
BiologyRadiation Biology and DNA damage signaling
Quantum dots for photosensitization




Jostein Dahle
Heidi Lyng
Randi Syljuåsen
Petras Juzenas
Vision: Our vision is to develop a radiobiological understanding of response to ionizing and non-ionizing radiation on the molecular, cellular and physiological level, and to utilize this knowledge in designing new strategies for the treatment of cancer. Our research strategy involves basic radiobiological research, translational and clinical studies.
Goals:
- to understand the molecular and physiological mechanisms behind tumour response to radiation, and to develop predictive methods and treatment strategies
- to understand the molecular mechanisms behind radiation induced malignancies, with special emphasis on genomic instability, and to unveil the relation between tissue architecture and normal tissue response following radiation therapy
- to develop treatment strategies utilizing non-ionizing radiation combined with photosensitizing agents, either to induce tumour cell kill directly or via internalization of therapeutic or sensitizing agents.
The Department has about 40 people altogether.
The permanent staff consists of 6 senior scientists and 8 technicians, while the rest are funded by external sources, primarily The Norwegian Cancer Society and The Norwegian Research Council.
May 7, 2012
Latest publications
Dept. of Radiation Biology
Corneal astigmatism correction with scleral flaps in trans-scleral suture-fixed posterior chamber lens implantation: a preliminary clinical observation
Int J Ophthalmol, 4 (5), 502-7
PubMed 22553711
Distance vision after bilateral implantation of AcrySof toric intraocular lenses: a randomized, controlled, prospective trial
Int J Ophthalmol, 4 (2), 175-8
PubMed 22553636
Blebbistatin, a myosin inhibitor, is phototoxic to human cancer cells under exposure to blue light
Biochim Biophys Acta, 1820 (7), 870-877 (in press)
PubMed 22507270
More publications








Print this page
